We are live on ! Find out more
EBS icon

Emergent Biosolutions
EBS

176 hedge funds and large institutions have $1.03B invested in Emergent Biosolutions in 2017 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 71 increasing their positions, 67 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% more repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 67

0.81% less ownership

Funds ownership: 88.25% → 87.44% (-0.81%)

12% less capital invested

Capital invested by funds: $1.17B → $1.03B (-$140M)

15% less funds holding

Funds holding: 208 → 176 (-32)

35% less call options, than puts

Call options by funds: $370K | Put options by funds: $568K

63% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 40

Holders
176
Holders Change
-32
Holders Change %
-15.38%
% of All Funds
4.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
71
Reduced
67
Closed
40
Calls
$370K
Puts
$568K
Net Calls
-$198K
Net Calls Change
-$711K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$128M
2
Millennium Management
Millennium Management
New York
+$16.7M
3
AAM
Aberdeen Asset Management
United Kingdom
+$11.3M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$8.84M
5
GT
Glenmede Trust
Pennsylvania
+$7.75M

Top Sellers

Rank Fund Capital Flow
1
MFIMFI
Mesirow Financial Investment Management - Fixed Income
Illinois
-$16M
2
Goldman Sachs
Goldman Sachs
New York
-$12.9M
3
PRCM
Pine River Capital Management
Minnesota
-$9.33M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$7.75M
5
LCP
Lombardia Capital Partners
California
-$7.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
Invesco
26
Invesco
Georgia
$9.91M +$798K +26,225 +8%
PCM
27
Peregrine Capital Management
Minnesota
$9.52M +$677K +22,232 +7%
Geode Capital Management
28
Geode Capital Management
Massachusetts
$9.12M +$790K +25,953 +9%
Arrowstreet Capital
29
Arrowstreet Capital
Massachusetts
$8.43M +$8.84M +290,266 New
Fidelity Investments
30
Fidelity Investments
Massachusetts
$8.39M +$14.7K +482 +0.2%
Principal Financial Group
31
Principal Financial Group
Iowa
$8.07M +$318K +10,446 +4%
MCM
32
Matarin Capital Management
New York
$7.48M +$913K +29,979 +13%
EAM
33
Eagle Asset Management
Florida
$6.89M -$197K -6,459 -3%
Federated Hermes
34
Federated Hermes
Pennsylvania
$6.88M -$119K -3,897 -2%
Bank of America
35
Bank of America
North Carolina
$6.82M +$1.72M +56,626 +32%
Ameriprise
36
Ameriprise
Minnesota
$6.44M +$207K +6,790 +3%
PI
37
Putnam Investments
Massachusetts
$5.47M -$448K -14,714 -7%
SO
38
STRS Ohio
Ohio
$5.19M +$213K +7,000 +4%
PAM
39
Panagora Asset Management
Massachusetts
$5.14M +$210K +6,891 +4%
KCM
40
Kennedy Capital Management
Missouri
$4.78M -$379K -12,454 -7%
AQR Capital Management
41
AQR Capital Management
Connecticut
$4.38M -$1.25M -40,945 -21%
Jacobs Levy Equity Management
42
Jacobs Levy Equity Management
New Jersey
$4.38M +$1.37M +45,160 +43%
TRSOTSOK
43
Teachers Retirement System of the State of Kentucky
Kentucky
$4.23M – – –
PPA
44
Parametric Portfolio Associates
Washington
$3.99M -$1.31M -42,994 -24%
Goldman Sachs
45
Goldman Sachs
New York
$3.8M -$12.9M -423,622 -76%
MOACM
46
Mutual of America Capital Management
New York
$3.78M -$1.69M -55,603 -30%
ERSOT
47
Employees Retirement System of Texas
Texas
$3.72M -$639K -21,000 -14%
GAM
48
Gotham Asset Management
New York
$3.49M -$1.38M -45,351 -27%
Bank of Montreal
49
Bank of Montreal
Ontario, Canada
$3.29M +$14.4K +473 +0.4%
QI
50
QS Investors
New York
$3.25M – – –
1
2
3 4 5

EBS Hedge Fund Activity: Q1 2017 in Review

176 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q1 2017, worth a combined $1.03B — down 12% from $1.17B a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of EBS and 15 opened new positions — a net loss of 25 holders — while 67 trimmed existing stakes and 71 added.

The largest buyer was BlackRock, adding an estimated $128M. The largest seller was Mesirow Financial Investment Management - Fixed Income, exiting entirely with an estimated $16M sold.

  • 176 institutional investors held Emergent Biosolutions (EBS) as of Q1 2017, down from 208 in Q4 2016.
  • Funds reported $1.03B of Emergent Biosolutions stock for Q1 2017, down 12% quarter-over-quarter.
  • 15 funds opened new Emergent Biosolutions positions in Q1 2017 and 40 closed out, a net change of -25 holders.
  • The largest Emergent Biosolutions buyer in Q1 2017 was BlackRock, an estimated $128M added.
  • The largest Emergent Biosolutions seller in Q1 2017 was Mesirow Financial Investment Management - Fixed Income, an estimated $16M sold.

Based on aggregated 13F filings for Q1 2017.